Natera seeks Japan’s PMDA approval for Signatera test in MIBC
The new application is supported by data from IMvigor011, a randomised, double-blind Phase III clinical trial.
Analysis
View MoreTracking carbon, tracing change
To track and verify embodied emissions through every stage of the supply chain, leading OEMs are piloting blockchain-anchored digital product passports (DPPs). Ellie Philpotts talks to Chris Taylor, sustainability lead...
Go with the flow
Harnessing automation
How smart can it be?
Killer nanopatterns